INNOPRAN Drug Patent Profile
✉ Email this page to a colleague
When do Innopran patents expire, and when can generic versions of Innopran launch?
Innopran is a drug marketed by Ani Pharms and is included in one NDA.
The generic ingredient in INNOPRAN is propranolol hydrochloride. There are twenty-two drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the propranolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Innopran
A generic version of INNOPRAN was approved as propranolol hydrochloride by INNOGENIX on October 22nd, 1985.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for INNOPRAN?
- What are the global sales for INNOPRAN?
- What is Average Wholesale Price for INNOPRAN?
Summary for INNOPRAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for INNOPRAN |
| DailyMed Link: | INNOPRAN at DailyMed |
US Patents and Regulatory Information for INNOPRAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | INNOPRAN XL | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021438-001 | Mar 12, 2003 | BX | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ani Pharms | INNOPRAN XL | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021438-002 | Mar 12, 2003 | BX | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
